FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, in particular to a method for evaluating a blood coagulation reaction. Method is proposed for evaluating the blood coagulation reaction, which is mediated by a substance having the activity of replacing the VIII blood coagulation factor; use of a blood coagulation initiation reagent in a method for evaluating a blood coagulation reaction; kit for assessing the reaction of coagulation of blood.
EFFECT: above method is an accurate assessment of biospecific antibodies in relation to their effect in the treatment of hemorrhagic diseases.
9 cl, 2 dwg
Authors
Dates
2019-04-03—Published
2013-09-26—Filed